Hard to guess when NCM will get the assays back from the deep drilling at Zipa + Havieron North targets. Speculation could be that they already know they're good which would confirm the expansion potential of Havieron so have gone for the 5% option. Speculation could also be that NCM will take out GGP. That would lead to the possibilty that if ARV nearby drilling is successful then ARV might be the next target.
Pure speculation only but who knows for sure. Great potential for ARV IMO.
Bring on the assays!
- Forums
- ASX - By Stock
- Ann: Additional High-Grade Au and Cu Intercepts Carlow East Zone
Hard to guess when NCM will get the assays back from the deep...
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARV (ASX) to my watchlist
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.25M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $17.64K | 1.979M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 569830 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 724428 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 569830 | 0.009 |
5 | 1315260 | 0.008 |
6 | 824711 | 0.007 |
4 | 985160 | 0.006 |
4 | 3400001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 724428 | 6 |
0.011 | 8189496 | 11 |
0.012 | 475001 | 2 |
0.013 | 840271 | 3 |
0.014 | 646916 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
ARV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online